Parkinsons Platform Growing demand for objective motor assessment in Parkinson’s care presents a clear expansion path for Kelvin. Target clinics, research institutions, and pharma managing clinical trials can leverage the platform to replace subjective scoring with objective, reproducible metrics.

Remote Assessment The device-agnostic nature of Kelvin enables remote or in-clinic deployments via smartphones and tablets, opening opportunities with telehealth providers, community health programs, and multi-site studies seeking scalable motor assessment solutions.

Clinical Trial Fit Industry interest in standardized, quantitative endpoints makes Kelvin attractive for phase II/III trials requiring reliable motion metrics. Partnerships with CROs and pharma sponsors could accelerate adoption and co-development of trial-ready workflows.

Cloud and Data Utilizing AWS, Docker, and associated tech stack supports scalable data storage, secure video handling, and repeatable deployments. This can be pitched to larger clinics and research centers prioritizing compliance, security, and performance.

Growth Readiness With under $1M in annual revenue and recent funding of $654K, there is room to position the company for strategic partnerships, reseller arrangements, and accelerated onboarding services to boost adoption among early customers and key geographies.